Clinical Trials Logo

Clinical Trial Summary

Atotal of 150 consecutive patients with chronic supraspinatous tendinopathy were invited to participate in the study .patients were recruited from the out patient clinic of rheumatology and rehabilitation department,Mansoura university hospital

a. perineural injection therapy group (subcutaneous prolotherapy) This group included 30 patients aged from 18 to 60 years Deep prolotherapy injection group The injection fluid contain 1 ml of 255 glucose and 1ml of lidocaine. The pathological area of the supraspinatous tendon was identified and graded using ultrasound pathology rating scale guided by ultrasonography (Simens Acuson p300 machine) Proper preparation with antiseptic solution of skin overlying the point of injection .


Clinical Trial Description

Baseline Evaluation

All patients were subjected to the following:

1. Thorough History Taking

1. Personal history: collected data include: age, sex, marital status, handedness, special habits and the current occupation.

2. Complaint in the patient's own words.

3. Present History he current symptoms, mode of onset, duration, , factors that may aggravate or relieve pain Characters of pain (dull aching,sharp pain ,burning sensation ,parasthesia). Distribution of pain . Review of systems: symptoms related to rheumatic conditions in particular conditions with predilection for shoulder joint affection.

Symptoms suggestive of medical disorders e.g. diabetes mellitus or thyroid dysfunction.

4. Past History Previous significant trauma(direct or occupational) orsugery to shoulder. Previous steroid injection to the shoulder. Previous injection of any type of regenerative medicine (as prp)

2. Thorough General Examination

1. General condition.

2. Vital signs (pulse, blood pressure, respiratory rate, body temperature)

3. Examination of systems (chest,cardiovascular,abdominal,neurological) to identify medical condition that may cause shoulder pain.

3-Muscloskeletal examination

1. General muscloskeletal examination

Examination of all joints for :

I.deformity,visible swelling or muscle atrophy II.Palpation for tenderness,warmth,palpable swelling either bony enlargement or synovial effusion.

III.Abnormalities in range of motion. IV.Diffuse muscloskeletal pain. V.Abnormalities of gait. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03942640
Study type Interventional
Source Mansoura University
Contact Reham M. Shaat
Phone 01224082636
Email rehamshaat@gmail.com
Status Recruiting
Phase N/A
Start date June 1, 2019
Completion date January 1, 2021

See also
  Status Clinical Trial Phase
Completed NCT02196948 - Electrolysis Percutaneous Therapeutic (EPTE) for Supraspinatus Tendinopathy N/A